Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of “Hold” by Analysts
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target […]
More Stories
William M. Sheriff Sells 24,000 Shares of enCore Energy Corp. (NASDAQ:EU) Stock
enCore Energy Corp. (NASDAQ:EU – Get Free Report) Director William M. Sheriff sold 24,000 shares of the company’s stock in...
Challenger Energy Group (LON:CEG) Trading 9.1% Higher – Still a Buy?
Challenger Energy Group PLC (LON:CEG – Get Free Report) traded up 9.1% on Friday . The company traded as high...
Aequus Pharmaceuticals (CVE:AQS) Sets New 52-Week Low – Should You Sell?
Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday ....
Vanguard S&P Small-Cap 600 Growth ETF (NYSEARCA:VIOG) Sees Unusually-High Trading Volume – What’s Next?
Shares of Vanguard S&P Small-Cap 600 Growth ETF (NYSEARCA:VIOG – Get Free Report) saw an uptick in trading volume on...
SSR Mining (NASDAQ:SSRM) Shares Up 4.8% – Still a Buy?
Shares of SSR Mining Inc. (NASDAQ:SSRM – Get Free Report) (TSE:SSO) shot up 4.8% during trading on Wednesday . The...
Boardwalk Real Estate Investment Trust (OTCMKTS:BOWFF) Hits New 52-Week Low – Here’s What Happened
Boardwalk Real Estate Investment Trust (OTCMKTS:BOWFF – Get Free Report)’s stock price hit a new 52-week low during mid-day trading...